News
April 14, 2009
MDCI to Present at Advamed Emerging Growth Company Conference
Senior staff will offer strategies for continued medical device development during difficult economy
MDCI, a leading CRO and regulatory consulting firm for the medical device industry , will present at the AdvaMed 9th Emerging Growth Company Conference, May 4 and 5 in Irvine, CA. The conference will addresses issues of particular concern to CEOs and senior-level executives from medical device manufacturers with sales less than $100 million.
While the global economic downturn has put increased pressure on small medical device firms to curtail spending and has limited the available sources of venture funding, there are still opportunities for these innovative companies to continue product development while avoiding significant capital expenditures.
Ron Warren, principal consultant and Michael Feldstein, Ph.D., vice president and principal biostatistician, will present a variety of clinical trial and regulatory strategies that forward-thinking companies can employ to add value to their technology, demonstrate incremental progress toward FDA 510(k) clearance or PMA approval, and position themselves for significant investment in pivotal clinical trials and regulatory approvals as the economic outlook improves.
A complete agenda and registration details are available at
http://www.advamedegcc.org/go.cfm?do=Page.View&pid=66
Contact Us
Reach our Massachusetts office at 1-508-643-0434, Monday through Friday, 9:00 a.m. to 5:00 p.m. Eastern. Or fill out our contact form and a consultant will contact you directly.